All News
Filter News
Found 265 articles
-
KemPharm, Inc. Appoints Todd Johnson, Ph.D. as Chief Commercial Officer
6/23/2010
-
KemPharm, Inc. Announces Entering Into an Exclusive Supply Agreement With Johnson Matthey Inc. for KP201
5/18/2010
-
KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP106 for ADHD
1/11/2010
-
KemPharm, Inc. Announces Initiation of Phase 1 Trial of KP106 for ADHD
10/22/2009
-
KemPharm, Inc. Expands Prodrug Pipeline with Candidate for Treatment of Pain and Closes Series B Financing
9/16/2009